Potential ways to improve survival for cancer patients who receive fragmented care
(American College of Surgeons) New research reveals that 28 percent of patients who are readmitted to the hospital with complications after surgical removal of pancreatic, liver, or stomach cancer go to a different hospital for follow-up care. This fragmentation of health care is associated with a 50 percent increased odds of dying, according to a study published online by the Journal of the American College of Surgeons ahead of print. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 15, 2021 Category: Cancer & Oncology Source Type: news

Dannielle Engle awarded prestigious pancreatic cancer research grant
(Salk Institute) Salk Assistant Professor Dannielle Engle was selected as the first recipient of the Lustgarten Foundation-AACR Career Development Award for Pancreatic Cancer Research in Honor of Ruth Bader Ginsburg, the late Supreme Court Justice and women's rights pioneer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 14, 2021 Category: Cancer & Oncology Source Type: news

Eckert & Ziegler secures technetium licenses for Brazil
Isotope technology firm Eckert & Ziegler has secured a license to marke...Read more on AuntMinnie.comRelated Reading: Eckert & Ziegler breaks ground on U.S. facility Isotopia, Eckert & Ziegler partner Eckert & Ziegler to open U.S. isotope facility Eckert & Ziegler reports loss in Q4 Eckert & Ziegler to produce pancreatic cancer agent (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 12, 2021 Category: Radiology Source Type: news

Mutant KRAS and p53 cooperate to drive pancreatic cancer metastasis
(University of Texas M. D. Anderson Cancer Center) MD Anderson researchers have discovered that mutant KRAS and p53, the most frequently mutated genes in pancreatic cancer, interact to promote metastasis and tumor growth. The findings point to a new therapeutic target for this deadly cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 10, 2021 Category: Cancer & Oncology Source Type: news

Immune-stimulating drug before surgery shows promise in early-stage pancreatic cancer
(University of Pennsylvania School of Medicine) Giving early-stage pancreatic cancer patients a CD40 immune-stimulating drug helped jumpstart a T cell attack to the notoriously stubborn tumor microenvironment before surgery and other treatments, according to a new study from researchers in the Abramson Cancer Center at the University of Pennsylvania. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 10, 2021 Category: International Medicine & Public Health Source Type: news

MD Anderson and TriSalus Life Sciences announce strategic research collaboration to evaluate treatment of solid tumors
(University of Texas M. D. Anderson Cancer Center) MD Anderson and TriSalus announced a strategic research collaboration to evaluate the treatment of liver and pancreas tumors with the investigational therapy SD-101 in combination with immunotherapy using a novel delivery approach. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 8, 2021 Category: International Medicine & Public Health Source Type: news

Surgery Can Boost Outcomes After Chemo for People With Pancreatic Cancer
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - March 31, 2021 Category: Cancer & Oncology Tags: Family Medicine, Oncology, Surgery, News, Source Type: news

Surgery Can Boost Outcomes After Chemo for People With Pancreatic Cancer
WEDNESDAY, March 31, 2021 -- Even in patients with stage 2 pancreatic cancer, surgery is typically worthwhile after chemotherapy, because it appears to extend patients'lives, a new study concludes. In stage 2 cancer, the tumor has already grown... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 31, 2021 Category: General Medicine Source Type: news

Surgery Can Boost Outcomes After Chemo for People With Pancreatic Cancer
Title: Surgery Can Boost Outcomes After Chemo for People With Pancreatic CancerCategory: Health NewsCreated: 3/31/2021 12:00:00 AMLast Editorial Review: 3/31/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - March 31, 2021 Category: Cancer & Oncology Source Type: news

Bluestar Genomics gains FDA Breakthrough Device designation for pancreatic can
(EAG Advertising& Marketing) Bluestar Genomics announces today it received U.S. Food and Drug Administration (FDA) Breakthrough Device designation for its proprietary noninvasive pancreatic cancer detection test in patients with new-onset diabetes. The FDA's Breakthrough Device program accelerates the development of medical devices that have the potential to effectively treat or diagnose life-threatening or irreversibly debilitating diseases. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - March 31, 2021 Category: Biology Source Type: news

New clinical trial studies pancreatic cancer tumor traits to uncover better treatments
(Stand Up To Cancer) A new team of pioneering pancreatic cancer researchers has been formed to predict which treatments might work best for individual pancreatic cancer patients based on the molecular traits of tumors. The Pancreatic Cancer Convergence Dream Team is funded by the Pancreatic Cancer Collective, an initiative of the Lustgarten Foundation and Stand Up To Cancer ® (SU2C), SU2C Canada and Pancreatic Cancer Canada. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 30, 2021 Category: Cancer & Oncology Source Type: news

Getting a Prescription to Die Remains Tricky Even As Aid-in-Dying Bills Gain Momentum Across the U.S.
Linda Heim knew her dad didn’t plan to wait for the cancer to kill him. For decades, he’d lived in Montana, which they’d thought was one of the few places where terminally ill people could get a prescription to end their life. After two years of being sick, Heim’s dad got the diagnosis in 2019: stage 4 kidney cancer. His physician offered treatments that might extend his life by months. Instead, the 81-year-old asked the doctor for help dying. Heim said her parents left the appointment in their hometown of Billings with two takeaways: The legality of medically assisted death was questionable in Mont...
Source: TIME: Health - March 29, 2021 Category: Consumer Health News Authors: Katheryn Houghton / Kaiser Health News Tags: Uncategorized COVID-19 Source Type: news

Surgery is a viable treatment for pancreatic cancer patients especially after chemotherapy
(American College of Surgeons) Patients with stage II pancreatic cancer who are treated with chemotherapy followed by resection (an operation that removes the cancerous part of the organ, structure or tissue) live nearly twice as long as patients who receive only chemotherapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 26, 2021 Category: Cancer & Oncology Source Type: news

UCLA researchers receive $6 million from NIH to explore new pancreatic cancer therapies
A team of researchers from theUCLA Jonsson Comprehensive Cancer Center has been awarded two research grants totaling $6 million from the National Institutes of Health to identify new ways to treat pancreatic cancer.Pancreatic cancer is the third leading cause of cancer-related mortality in the United States, accounting for more than 47,000 deaths annually. Only 1 in 10 people diagnosed with this particularly aggressive disease live beyond five years, and most therapies — including conventional chemotherapies, targeted therapies and immunotherapies — are unsuccessful in treating it.“Pancreatic cancer is on...
Source: UCLA Newsroom: Health Sciences - March 25, 2021 Category: Universities & Medical Training Source Type: news

UCLA team receives $6 million from NIH to explore new pancreatic cancer therapies
(University of California - Los Angeles Health Sciences) A team of researchers from the UCLA Jonsson Comprehensive Cancer Center has been awarded two research grants totaling $6 million from the National Institutes of Health to identify new ways to treat pancreatic cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 25, 2021 Category: Cancer & Oncology Source Type: news

Why 2020 was the year of marvellous medicine
A vaccine that could treat multiple types of tumours and stop the cancer from returning has been created in Australia. It could be used against breast, lung, ovarian, kidney and pancreatic cancers. (Source: the Mail online | Health)
Source: the Mail online | Health - March 23, 2021 Category: Consumer Health News Source Type: news

Pancreatic cancer symptoms: Five visual warning signs in your poo - 'grey and oily'
PANCREATIC cancer may not have any symptoms, or they might be hard to spot. When they do arise, you may notice a number of changes in your poo. (Source: Daily Express - Health)
Source: Daily Express - Health - March 22, 2021 Category: Consumer Health News Source Type: news

Ablative Radiation Extends Life in Unresectable Pancreatic Cancer Ablative Radiation Extends Life in Unresectable Pancreatic Cancer
Increasing the radiation dose by making adjustments for respiratory and gastrointestinal functions improves the outcome, when given with induction chemotherapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 19, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Pancreatic cancer symptoms: Difficulty flushing poo could be a warning sign
PANCREATIC cancer is deadly - it "has the lowest survival of all common cancers", warned the charity Pancreatic Cancer UK. This is why it's crucial to get treatment as soon as possible. (Source: Daily Express - Health)
Source: Daily Express - Health - March 19, 2021 Category: Consumer Health News Source Type: news

Reversing cancer's gluttony
(University of California - San Diego) Researchers at UC San Diego School of Medicine and Moores Cancer Center describe how pancreatic cancer cells use an alternative method to find necessary nutrients, defying current therapies, to help them grow and spread. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 18, 2021 Category: International Medicine & Public Health Source Type: news

Scientists shrink pancreatic tumors by starving their cellular 'neighbors'
(Sanford Burnham Prebys Medical Discovery Institute) Scientists at Sanford Burnham Prebys Medical Discovery Institute demonstrated for the first time that blocking " cell drinking, " or macropinocytosis, in the thick tissue surrounding a pancreatic tumor slowed tumor growth--providing more evidence that macropinocytosis is a driver of pancreatic cancer growth and is an important therapeutic target. The study was published in Cancer Discovery, a journal of the American Association for Cancer Research. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 17, 2021 Category: Cancer & Oncology Source Type: news

When will PET/MRI live up to its promise?
From its early days 10 years ago to the present, PET/MRI has developed fro...Read more on AuntMinnie.comRelated Reading: FDG-PET/MRI offers option for pediatric Hodgkin lymphoma PET/MRI, CT predict pancreatic cancer treatment response Use F-18 fluciclovine PET/MRI to stage prostate cancer PET/MRI boosts cancer detection PET/MRI ups lesion detection by 15% for some cancers (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 16, 2021 Category: Radiology Source Type: news

AI reduces FDG dose on PET imaging
An artificial intelligence (AI) algorithm can process F-18 FDG PET exams acquire...Read more on AuntMinnie.comRelated Reading: FDG-PET/MRI offers option for pediatric Hodgkin lymphoma FDG-PET/CT shows COVID-19 vaccine uptake Radiomics, AI can guide NSCLC treatment decisions PET/CT guidance offers valuable approach to lung biopsies PET/MRI, CT predict pancreatic cancer treatment response (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 12, 2021 Category: Radiology Source Type: news

Researchers to 3D-print living human pancreas for diabetes research
(Natural News) An international team of researchers will be 3D printing live human pancreas models as part of a research initiative called the “European ENLIGHT Project.” The researchers plan to use the “bioprinted” models to improve the testing of diabetes medications and eventually treatments for other diseases like cancer. The European Union‘s Horizon 2020 Innovation Fund awarded... (Source: NaturalNews.com)
Source: NaturalNews.com - March 10, 2021 Category: Consumer Health News Source Type: news

Therapy sneaks into hard layer of pancreatic cancer tumor and destroys it from within
(University of California - San Diego) Researchers at University of California San Diego School of Medicine and Moores Cancer Center demonstrated that a new tumor-penetrating therapy could enhance the effects of chemotherapy, reduce the spread of pancreatic cancer and increase survival in animal models. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - March 9, 2021 Category: Biology Source Type: news

Pancreatic cancer: Light coloured stools or dark coloured urine could indicate your risk
PANCREATIC cancer is the 10th most common cancer in the UK with warning signs of your risk found in the colour of your stools and urine. What else should you look out for? (Source: Daily Express - Health)
Source: Daily Express - Health - March 5, 2021 Category: Consumer Health News Source Type: news

Collagen plays protective role during pancreatic cancer development
(University of Texas M. D. Anderson Cancer Center) Contrary to long-held beliefs, new research finds that collagen in the tumor microenvironment does not promote cancer development but plays a protective role in controlling pancreatic cancer growth. The new findings could have important therapeutic implications. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 4, 2021 Category: Cancer & Oncology Source Type: news

PET/MRI biomarkers guide personalized treatment for patients with pancreatic cancer
Positron emission tomography (PET)/MRI has changed how Mayo Clinic specialists treat patients with pancreatic cancer. Mayo Clinic pioneered the use of PET/MRI to manage pancreatic cancer. Now a new study by Ananya Panda, M.B.B.S., and colleagues systematically evaluates the strengths of PET/MRI for pancreatic ductal adenocarcinoma (PDAC). In less than five years, Mayo's PET/MRI practice [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 4, 2021 Category: Databases & Libraries Source Type: news

Pancreatic cancer symptoms: Indigestion may warn of the deadly disease
PANCREATIC cancer cases have risen six-fold since the 1990s, with the disease mainly diagnosed in the very late stages. Be aware of the warning signs so that any treatment can begin sooner. What are the symptoms? (Source: Daily Express - Health)
Source: Daily Express - Health - March 1, 2021 Category: Consumer Health News Source Type: news

Cancer Death Rates Continue to Fall in Europe, Except For... Cancer Death Rates Continue to Fall in Europe, Except For...
Cancer death rates overall continue to fall in the EU, with the exception of pancreatic cancer in both sexes and lung cancer among women.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 23, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

What Is the #1 Cause of Pancreatic Cancer
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - February 23, 2021 Category: General Medicine Source Type: news

What Is the Cause of Pancreatic Cancer
What Is the #1 Cause of Pancreatic Cancer? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - February 23, 2021 Category: General Medicine Source Type: news

New insights on how inflammatory molecule contributes to skin and pancreatic cancers
(Massachusetts General Hospital) An immune molecule called interleukin-33 can act within a cell's nucleus to stimulate abnormal growth and division, ultimately resulting in cancer. Targeting interleukin-33 in the nucleus may help prevent certain cancers. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 22, 2021 Category: International Medicine & Public Health Source Type: news

Investment needed to bring down pancreatic cancer death rates in Europe
(European Society for Medical Oncology) Researchers have called on European policymakers to make adequate resources available to tackle pancreatic cancer, a disease that is almost invariably fatal and where little progress has been made over the past 40 years. The latest predictions for cancer deaths in the EU and UK for 2021, published in the leading cancer journal Annals of Oncology, show that pancreatic death rates are predicted to remain approximately stable for men, but continue to rise in women in most EU countries. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 21, 2021 Category: Cancer & Oncology Source Type: news

UCLA study finds combination therapy suppresses pancreatic tumor growth in mice
(University of California - Los Angeles Health Sciences) UCLA Jonsson Comprehensive Cancer Center researchers have uncovered a potential new way to target pancreatic tumors that express high intratumoral interferon signaling (IFN). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 18, 2021 Category: Cancer & Oncology Source Type: news

Drug is promising against pancreatic and breast cancers
(Georgia State University) The drug is effective at treating pancreatic cancer and prolonging survival in mice, according to a study published in the journal Cellular and Molecular Gastroenterology and Hepatology. A second study, published in the Journal of Experimental Medicine, shows the drug is also effective against triple-negative breast cancer, a fast-growing and hard-to-treat type of breast cancer that carries a poor prognosis. Clinical trials are set to begin in 2021. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 9, 2021 Category: Cancer & Oncology Source Type: news

ATDC KEAPs NRF2 active
ATDC promotes pancreatic cancer progression and chemoresistance by disrupting KEAP1-mediated ubiquitylation of NRF2. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - February 9, 2021 Category: Science Authors: VanHook, A. M. Tags: STKE Editors ' Choice Source Type: news

Covid and cancer: 'A stranger helped me cope with my terminal illness'
Minna Heeraman's surgery for pancreatic cancer was delayed because of the coronavirus pandemic. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - February 7, 2021 Category: Consumer Health News Source Type: news

How Scientists Shot Down Cancer ’s ‘Death Star’
No drug could touch a quivering protein implicated in a variety of tumors. Then one chemist saw an opening. (Source: NYT Health)
Source: NYT Health - February 5, 2021 Category: Consumer Health News Authors: Gina Kolata Tags: Lung Cancer Pancreatic Cancer Colon and Colorectal Cancer Drugs (Pharmaceuticals) Smoking and Tobacco Lungs Genetics and Heredity Tumors Pancreas Clinical Trials Amgen Inc United States Source Type: news

Pancreatic cancer: What do your faeces smell like? Hidden warning sign found in your poo
PANCREATIC cancer symptoms are often non-specific and vague in the beginning. One of the first noticeable signs is the smell of your faeces. (Source: Daily Express - Health)
Source: Daily Express - Health - February 4, 2021 Category: Consumer Health News Source Type: news

New biomarker may predict which pancreatic cancer patients respond to CD40 immunotherapy
(University of Pennsylvania School of Medicine) Inflammation in the blood could serve as a new biomarker to help identify patients with advanced pancreatic cancer who won't respond to the immune-stimulating drugs known as CD40 agonists, suggests a new study from researchers in the Abramson Cancer Center of the University of Pennsylvania published inJCI Insight. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 4, 2021 Category: Cancer & Oncology Source Type: news

MSK scientists learn how genes and environment conspire in pancreatic cancer development
(Memorial Sloan Kettering Cancer Center) Both genes and environment are necessary to trigger pancreatic cancer development. A new study from Memorial Sloan Kettering researchers explains why. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 3, 2021 Category: Cancer & Oncology Source Type: news

Perioperative Chemo Feasible for Resectable Pancreatic Cancer
Phase 2 randomized trial revealed similar overall survival for two active regimens compared with adjuvant therapy (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 2, 2021 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Pharmacy, Radiology, Surgery, Journal, Source Type: news

Perioperative Chemo Feasible for Resectable Pancreatic Cancer
TUESDAY, Feb. 2, 2021 -- Perioperative chemotherapy for resectable pancreatic cancer is safe and effective, but it did not improve overall survival (OS) compared with historical data from trials of adjuvant therapy, according to a study published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 2, 2021 Category: Pharmaceuticals Source Type: news

Nanoparticle drug delivery technique shows promise for treating pancreatic cancer
(Veterans Affairs Research Communications) Veterans Affairs researchers have designed a new way to deliver pancreatic cancer drugs that could make fighting the disease much easier. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 28, 2021 Category: International Medicine & Public Health Source Type: news

Mechanism for how pancreatic cancer evades immunotherapy elucidated
(Georgetown University Medical Center) Pancreatic cancer, one of the most lethal of all cancers, is capable of evading attacks by immune cells by changing its microenvironment so that the immune cells suppress, rather than support, an attack on the tumor. The scientists also found that that some of the mediators of this suppressive response, including a protein called STAT1, represent potential therapeutic targets that could be used to reverse this evasion and point to possible treatment opportunities. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 28, 2021 Category: Cancer & Oncology Source Type: news

High Cost of Pancreatic Enzymes a Barrier for Patients With Cancer High Cost of Pancreatic Enzymes a Barrier for Patients With Cancer
These products are often essential for the treatment of pancreatic cancer, but out-of-pocket costs for a 30-day supply on Medicare can reach $1000 or more.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 26, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Researchers develop virus-based treatment platform to fight pancreatic cancer
(Queen Mary University of London) Researchers from Queen Mary University of London and Zhengzhou University have developed a powerful therapeutic platform that uses a modified virus for the treatment of pancreatic cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 26, 2021 Category: Cancer & Oncology Source Type: news

Opioid Use May Contribute to Risk for Pancreatic Cancer
At the state level, opioid death rate at four years prior predicted the initial incidence of pancreatic cancer (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 22, 2021 Category: Cancer & Oncology Tags: Family Medicine, Gastroenterology, Internal Medicine, Oncology, Pharmacy, Anesthesiology & amp; Pain, Journal, Source Type: news

Opioid Use May Contribute to Risk for Pancreatic Cancer
FRIDAY, Jan. 22, 2021 -- Opioid use seems to contribute to the increasing incidence of pancreatic cancer (PC) in the United States, according to a study published online Jan. 6 in PLOS ONE. Usman Barlass, M.D., from Rush University Medical Center... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 22, 2021 Category: Pharmaceuticals Source Type: news